1. Home
  2. WS vs ATAI Comparison

WS vs ATAI Comparison

Compare WS & ATAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Worthington Steel Inc.

WS

Worthington Steel Inc.

HOLD

Current Price

$39.22

Market Cap

2.0B

Sector

N/A

ML Signal

HOLD

ATAI

ATAI Life Sciences N.V.

HOLD

Current Price

$4.02

Market Cap

1.6B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
WS
ATAI
Founded
1955
2018
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.0B
1.6B
IPO Year
2023
2025

Fundamental Metrics

Financial Performance
Metric
WS
ATAI
Price
$39.22
$4.02
Analyst Decision
Buy
Strong Buy
Analyst Count
2
8
Target Price
$42.50
$15.88
AVG Volume (30 Days)
201.6K
5.1M
Earning Date
03-25-2026
05-11-2026
Dividend Yield
1.76%
N/A
EPS Growth
N/A
N/A
EPS
1.30
N/A
Revenue
$3,093,300,000.00
$4,089,000.00
Revenue This Year
$16.77
N/A
Revenue Next Year
$2.69
N/A
P/E Ratio
$31.27
N/A
Revenue Growth
N/A
1227.60
52 Week Low
$27.22
$2.00
52 Week High
$49.17
$6.73

Technical Indicators

Market Signals
Indicator
WS
ATAI
Relative Strength Index (RSI) 43.49 48.26
Support Level $38.01 $3.89
Resistance Level $39.29 $4.20
Average True Range (ATR) 2.00 0.33
MACD -0.43 -0.03
Stochastic Oscillator 1.73 29.32

Price Performance

Historical Comparison
WS
ATAI

About WS Worthington Steel Inc.

Worthington Steel Inc is a processor of carbon flat-rolled steel, a producer of laser-welded solutions, and a provider of electrical steel laminations. The company has manufacturing facilities across the United States, Canada, China, India, Germany and Mexico. It buys coils of steel from primary steel producers and processes them to precise type, thickness, length, width, shape, and surface quality required by customer specifications. The company's product lines and processing capabilities include; carbon flat-rolled steel processing, electrical steel laminations, and tailor welded products. Geographically, the company generates a majority of its revenue from the United States followed by Canada, Mexico, and other regions.

About ATAI ATAI Life Sciences N.V.

AtaiBeckley Inc is a clinical-stage biopharmaceutical company on a mission to transform patient outcomes by developing effective, rapid-acting, and convenient mental health treatments. AtaiBeckley's pipeline of novel therapies includes BPL-003 (mebufotenin benzoate nasal spray) for treatment-resistant depression (TRD), VLS-01 (DMT buccal film) for TRD, and EMP-01 ((R)-MDMA HCI) for social anxiety disorder, which are in Phase 2 clinical development.

Share on Social Networks: